• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种针对牙龈卟啉单胞菌II型菌毛蛋白A的单克隆抗体可抑制人牙龈成纤维细胞中白细胞介素-8的产生。

A monoclonal antibody against fimA type II Porphyromonas gingivalis inhibits IL-8 production in human gingival fibroblasts.

作者信息

Hijiya Takahiro, Shibata Yasuko, Hayakawa Mitsuo, Abiko Yoshimitsu

机构信息

Department of Biochemistry and Molecular Biology, Nihon University School of Dentistry at Matsudo, Matsudo, Chiba, Japan.

出版信息

Hybridoma (Larchmt). 2010 Jun;29(3):201-4. doi: 10.1089/hyb.2009.0109.

DOI:10.1089/hyb.2009.0109
PMID:20568993
Abstract

The periodontal pathogen Porphyromans gingivalis is classified into six groups (types I-V and Ib) based on the genotype of the fimbriae A (fimA) gene. Among genotypes, fimA type II strains are thought to be most strongly related to advanced periodontitis. The present study was undertaken to develop passive immunotherapy monoclonal antibodies (MAbs) against periodontitis, which are capable of inhibiting virulency and were constructed through the immunization of outer membrane vesicles (OMV) fraction of fimAII strain, TDC60, using mouse hybridoma technology. MAbs that recognized OMV by ELISA assay were identified, and 28 clones were screened by Western blot analysis. After purifying these MAbs using protein G column, the effect of the MAb on IL-8 production from human gingival fibroblasts by OMV was examined. We selected MAb TDC4-33H, which strongly inhibited the IL-8 production with a higher MAb production rate. Since the MAb showed an individual ladder-like profile against OMV by Western blotting, we further examined the reactivity against lipopolysaccharides (LPS) from TDC60, W83 (fimAIV), and ATCC33277 (fimAI). As a result, MAb TDC4-33H recognized all LPSs. Moreover, MAb TDC4-33H significantly inhibited the LPS-stimulated IL-8 production in human gingival fibroblasts. These findings suggest that MAb TDC4-33H reacts with LPS and may be useful for passive immunotherapy through neutralizing IL-8 production in gingival fibroblasts by P. gingivalis LPS.

摘要

牙周病原体牙龈卟啉单胞菌根据菌毛A(fimA)基因的基因型分为六组(I-V型和Ib型)。在这些基因型中,fimA II型菌株被认为与重度牙周炎关系最为密切。本研究旨在开发针对牙周炎的被动免疫治疗单克隆抗体(MAb),这些抗体能够抑制毒力,并通过小鼠杂交瘤技术,利用fimA II型菌株TDC60的外膜囊泡(OMV)组分进行免疫构建而成。通过ELISA检测识别OMV的单克隆抗体被鉴定出来,并通过蛋白质印迹分析筛选出28个克隆。使用蛋白G柱纯化这些单克隆抗体后,检测了该单克隆抗体对OMV诱导人牙龈成纤维细胞产生白细胞介素-8的影响。我们选择了单克隆抗体TDC4-33H,它能强烈抑制白细胞介素-8的产生,且单克隆抗体产生率较高。由于该单克隆抗体在蛋白质印迹中对OMV呈现出独特的阶梯状图谱,我们进一步检测了它对TDC60、W83(fimA IV型)和ATCC33277(fimA I型)的脂多糖(LPS)的反应性。结果,单克隆抗体TDC4-33H识别所有的脂多糖。此外,单克隆抗体TDC4-33H显著抑制脂多糖刺激人牙龈成纤维细胞产生白细胞介素-8。这些发现表明,单克隆抗体TDC4-33H与脂多糖反应,可能通过中和牙龈卟啉单胞菌脂多糖诱导牙龈成纤维细胞产生白细胞介素-8而用于被动免疫治疗。

相似文献

1
A monoclonal antibody against fimA type II Porphyromonas gingivalis inhibits IL-8 production in human gingival fibroblasts.一种针对牙龈卟啉单胞菌II型菌毛蛋白A的单克隆抗体可抑制人牙龈成纤维细胞中白细胞介素-8的产生。
Hybridoma (Larchmt). 2010 Jun;29(3):201-4. doi: 10.1089/hyb.2009.0109.
2
Monoclonal antibodies produced against lipopolysaccharide from fimA Type II Porphyromonas gingivalis.针对牙龈卟啉单胞菌II型菌毛蛋白A的脂多糖产生的单克隆抗体。
Hybridoma (Larchmt). 2009 Dec;28(6):431-4. doi: 10.1089/hyb.2009.0055.
3
Cloning and characterization of heavy and light chain genes encoding the FimA-specific monoclonal antibodies that inhibit Porphyromonas gingivalis adhesion.克隆和鉴定编码特异性 FimA 单克隆抗体的重链和轻链基因,该抗体能抑制牙龈卟啉单胞菌的黏附。
Microbiol Immunol. 2011 Mar;55(3):199-210. doi: 10.1111/j.1348-0421.2011.00305.x.
4
Heterogeneous expression of Toll-like receptor 4 and downregulation of Toll-like receptor 4 expression on human gingival fibroblasts by Porphyromonas gingivalis lipopolysaccharide.牙龈卟啉单胞菌脂多糖导致人牙龈成纤维细胞Toll样受体4的异质性表达及Toll样受体4表达下调。
Biochem Biophys Res Commun. 2001 Nov 9;288(4):863-7. doi: 10.1006/bbrc.2001.5842.
5
Soluble CD14-dependent intercellular adhesion molecular-1 induction by Porphyromonas gingivalis lipopolysaccharide in human gingival fibroblasts.牙龈卟啉单胞菌脂多糖通过可溶性CD14依赖途径诱导人牙龈成纤维细胞产生细胞间黏附分子-1
J Periodontol. 1999 Jul;70(7):772-8. doi: 10.1902/jop.1999.70.7.772.
6
IL-10 inhibits Porphyromonas gingivalis LPS-stimulated human gingival fibroblasts production of IL-6.白细胞介素-10抑制牙龈卟啉单胞菌脂多糖刺激的人牙龈成纤维细胞产生白细胞介素-6。
Biochem Biophys Res Commun. 1999 Sep 24;263(2):372-7. doi: 10.1006/bbrc.1999.1381.
7
Cytokine profiling of macrophages exposed to Porphyromonas gingivalis, its lipopolysaccharide, or its FimA protein.暴露于牙龈卟啉单胞菌、其脂多糖或其菌毛蛋白A的巨噬细胞的细胞因子分析。
Infect Immun. 2005 Feb;73(2):935-43. doi: 10.1128/IAI.73.2.935-943.2005.
8
Hyporesponsiveness of inflamed human gingival fibroblasts from patients with chronic periodontal diseases against cell surface components of Porphyromonas gingivalis.慢性牙周病患者炎症牙龈成纤维细胞对牙龈卟啉单胞菌细胞表面成分反应性降低。
FEMS Immunol Med Microbiol. 1997 May;18(1):17-30. doi: 10.1111/j.1574-695X.1997.tb01023.x.
9
Toll-like receptor 4-mediated signal pathway induced by Porphyromonas gingivalis lipopolysaccharide in human gingival fibroblasts.牙龈卟啉单胞菌脂多糖诱导人牙龈成纤维细胞中Toll样受体4介导的信号通路
Biochem Biophys Res Commun. 2000 Jul 14;273(3):1161-7. doi: 10.1006/bbrc.2000.3060.
10
Compromised inflammatory cytokine response to P. gingivalis LPS by fibroblasts from inflamed human gingiva.炎症性人牙龈成纤维细胞对 P. gingivalis LPS 的炎症细胞因子反应受损。
Clin Oral Investig. 2018 Mar;22(2):919-927. doi: 10.1007/s00784-017-2171-6. Epub 2017 Jul 8.

引用本文的文献

1
Outer membrane vesicles as a platform for the discovery of antibodies to bacterial pathogens.外膜囊泡作为发现针对细菌病原体抗体的平台。
Appl Microbiol Biotechnol. 2024 Feb 24;108(1):232. doi: 10.1007/s00253-024-13033-5.
2
outer membrane vesicles exacerbate retinal microvascular endothelial cell dysfunction in diabetic retinopathy.外膜囊泡会加剧糖尿病视网膜病变中视网膜微血管内皮细胞功能障碍。
Front Microbiol. 2023 May 11;14:1167160. doi: 10.3389/fmicb.2023.1167160. eCollection 2023.
3
Outer Membrane Vesicle-Host Cell Interactions.
外膜囊泡-宿主细胞相互作用。
Microbiol Spectr. 2019 Jan;7(1). doi: 10.1128/microbiolspec.PSIB-0001-2018.